INTRODUCTION
The American health care market simultaneously faces two precarious trends: rising costs and a growing shortage of primary care providers. As more medical school graduates opt for careers as specialists instead of as primary care providers (PCP), 1 the physician supply has stalled. But an aging population and millions of newly-insured Affordable Care Act beneficiaries have caused demand growth to speed up, and the field faces a 20,400-physician shortage by 2020.
2 This growing primary care shortage comes as health care prices grow faster than wages or inflation.
3
As these cost and supply problems intensify, nurse practitioners (NP) may be critical to meeting growing primary care needs at affordable costs. Nurse practitioners, a subset of advanced practice registered nurses (APRN), 4 hold postgraduate nursing degrees and are trained to diagnose and treat illnesses, order and interpret tests, and focus on health promotion, disease prevention and health education and counseling. The prevalence and importance of NPs began with the development of nurse practitioner programs amid 1960s health care expansion. 5 Today, nurse practitioners fill a variety of critical roles, including many traditionally associated with physicians.
6 Importantly, research on both patient satisfaction and outcomes shows that nurse practitioners provide comparable or superior quality to that of physicians. 7 In many states, however, regulatory barriers stand in the way of expanding NPs' role as primary care providers. These barriers include scope of practice laws that limit NPs' ability to work based on mandatory collaborative agreement contracts with physicians or physician supervision. Additionally, these barriers yield fragmented medical reimbursement regimes that stifle NPs' ability to be reimbursed as PCPs.
A growing chorus of key stakeholders has called for updating these regulatory regimes. A 2010 Institute of Medicine (IOM) report recommended that states reform scope-of-practice regulations and provide for direct NP reimbursement in order to allow nurses help meet the growing primary care shortage. 8 The National Governors Association has reported that nurse practitioners have been shown to provide comparable quality care to physicians and recommended that states consider easing scope-of-practice restrictions and modifying reimbursement policies to encourage greater NP involvement in primary care. 9 The Federal Trade Commission has recommended state legislators consider that scope-of-practice laws may deprive consumers of quality and cost benefits by placing unnecessary or overbroad competition restrictions on the primary care market. In May 2015, Maryland joined 20 other states and the District of Columbia in allowing nurse practitioners to practice independently, the seventh state in the last four years.
11 Pennsylvania remains among the states that restrict NPs' ability to practice and compete in the primary care marketplace by requiring NPs to practice under physician collaboration agreements, 12 prohibiting NPs from prescribing certain medications without physician collaboration, 13 and failing to provide for direct third-party reimbursement.
14 Policymakers are currently considering legislation that would grant NPs Full Practice Authority. This report surveys applicable research to assess the impact for Pennsylvanians that reform would have on access, quality, and cost of health care. That research suggests that Full Practice Authority could benefit Pennsylvanians by increasing access to comparable or higher quality health care and it could lower costs in the process. Reform would save Pennsylvanians at least $6.4 billion over a decade, increase the statewide nurse practitioner workforce by 13%, and improve the overall quality of primary care. Because there were no studies yielding Pennsylvania-specific results, we observed the results of studies on sets of states that were composed of both Pennsylvania and states with similar practicerestrictions to Pennsylvania. 15 The studies compared these states to states without such restrictions, considering restrictions' effects on one of three metrics: access, quality, and cost of health care. By applying these studies to Pennsylvania's demographic data, we yielded findings on how removal of the collaboration requirement would likely affect access, quality, and costs in Pennsylvania specifically.
We note here that these estimates are not intended as precise projections of exactly how changes would impact access, quality, and cost in Pennsylvania. Rather we surveyed the existing studies to find the best estimates of reform's impact and applied those studies' findings to available health care data for Pennsylvania. In doing so we endeavored to be conservative, and the benefits from reform for each measure could be even greater than this paper estimates. 17 See id. at 397. 18 Id. This is a conservative estimate, for the values in the study varied between 10 and 11 NPs per 100,000. Notably, the study found no significant difference between the "Most Restrictions" and "Some Restrictions" groups. HSA-level impact. Each HSA in Pennsylvania has a different concentration of NPs. Therefore, we determined NP-concentrations within HSAs if they grew proportionally to reflect a 10 NPper-100,000 increase statewide. Table 1 8 Example: Cameron, McKean, and Potter Counties. To get a glimpse of the current distribution of NPs with National Provider Identification (NPI) by county, see Figure 3 , below. 25 Other studies have used the distribution of NPs with NPI general proxy for distribution of all NPs. 26 Many of the counties that have the fewest absolute numbers of NPs belong to HSAs that also have low concentrations of NPs. For example, HSA #864 (McKean, Cameron, and Potter counties) is among the HSAs with the fewest NPs, with only about 27 total NPs. It also only has about half the statewide NP-concentration, with 40 NPs per 100,000 as opposed to 77 NPs per 100,000 statewide. Access to primary care is particularly challenging in these areas of Pennsylvania.
Fortunately, the increased access resulting from Full Practice Authority would provide tangible benefits for health care consumers in Pennsylvania. Not only would consumers have more provider choices, but they would enjoy the unique benefits NPs offer. NPs tend to work at more convenient times and at more convenient locations that are often difficult for more traditional providers like physicians to offer.
27 For example, NPs often work in retail-based clinics and walk-in clinics, among other convenient forums, whereas physicians generally do not. 28 Thus, reform would pass on Full Practice Authority's positive access impact to health care consumers in Pennsylvania, particularly those in underserved areas. In assessing reform's effect on quality, studies yield two key takeaways: (1) primary care from nurse practitioners is of comparable or superior quality to care by physicians, and (2) state's with Full Practice Authority enjoy overall higher quality primary care.
Quality of NP Care. Research shows that care provided by NPs is of equal or superior quality to that of physicians. For example, studies show patients report equal 29 or greater 30 levels of satisfaction with NP-provided care, and that NPs spend equal 31 or greater 32 amounts of time with patients during visits. Studies have also shown that patients of NPs are better able to achieve weight loss 33 and lower blood pressure, 34 and self-reported health statuses were higher among patients of NPs.
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Quality of Overall Primary Care. Research also shows that reform increases a state's overall quality of primary care. Kleiner et al. investigated whether easing scope-of-practice restrictions correlated with rises in adverse medical conditions, using infant mortality and malpractice insurance rates as proxies. The study found reform does not correlate with a rise in either one. 36 Additional research indicates that easing scope-of-practice regulations increases the overall quality of care based on subjective and objective measurements. Traczynski and Udalova assessed quality of overall primary care visits using patient reports of whether primary care providers spent enough time with them, whether patients felt providers listened to their concerns, and whether providers explained things in an understandable way. States without restrictive NP regulations scored better on all three. 37 Essentially, easing scope-of-practice laws frees physicians and nurse practitioners from spending burdensome hours on administrative requirements and allows both to spend more time with patients. Traczynski and Udalova also showed that in states that remove NP restrictions, annual checkups go up and avoidable emergency room visits go down.
Annual checkups. Traczynski and Udalova designated those states requiring supervisory or collaborative control over any aspect of NP practice as "dependent" and those without restrictions as "independent." 39 Controlling for age, race, health insurance status, ethnicity, gender, urban residency, employment status, marital status, education, and income, the study found that 66% of adults got yearly checkups, 40 but 70% got yearly checkups during 1-2 years after reform, and 72.8% got yearly checkups during year 10 after reform. 41 Pennsylvania was contained in the "dependent" category for this study by virtue of its restrictions on both practice and prescriptive authority. Data for Pennsylvania's particular checkup-rate is prohibitively difficult to obtain for the purposes of this piece, but a comparable increase in annual adult checkups would mean more than half-a-million additional Pennsylvanians getting yearly checkups by year 10.
42
Emergency room visits. Traczynski and Udalova also found a significant long-term reduction in avoidable emergency room visits after granting NP independence. 43 The study investigated emergency room visits for ambulatory care sensitive (ACS) conditions, which are "diagnoses for which timely and effective outpatient care can help . . . by either preventing the onset of an illness or condition, controlling an acute episodic illness or condition, or managing a chronic disease or condition."
44 Data showed a 21.7% decrease in ACS emergency room visits, 45 which is 0.25 fewer emergency room visits per ACS condition per year.
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In all, Full Practice Authority is correlated with healthier citizens, which may be explained by the high-quality care NPs deliver but also by the reduced burden for both physicians and NPs when they are freed from the administration requirements that come with collaboration agreements.
METRIC #3: MEASURING THE EFFECT ON COST
NPs provide quality care at lower costs. Reducing barriers to effective NP practice could save Pennsylvanians more than $6.4 billion over ten years.
To estimate how Full Practice Authority would affect health care costs in Pennsylvania, we reviewed a variety of studies that estimated cost savings from granting NP independence. We began by observing a North Carolina study by Conover et al. 47 That study estimated savings in North Carolina between 0.63% and 6.2% of total health care expenditures over ten years. 48 The 0.63% figure was drawn from a RAND Corporation study on the effects of NP independence in Massachusetts. 49 The 6.2% figure was drawn from a Perryman Group study estimating reform's impact in Texas. 50 Conover et al. predicted that North Carolina's total health care savings would amount to more than the RAND Corporation figure of 0.63% of total health expenditures, yielding savings of more than $433 million per year (based total health expenditures of on $66.8 billion per year). Conover based this conclusion on a number of factors:
The RAND figure represented phased-in savings over five years, which may be slower than in North Carolina (without phasing in, the savings would be 0.73%).
• The RAND figure entirely excludes medical savings such as lower hospitalizations.
• The RAND figure only includes potential savings from NPs, not from CNMs, CRNAs, or CNSs.
• North Carolina regulations are more restrictive than in Massachusetts. 51 Conover concluded that North Carolina's savings would probably fall within the 0.63%-6.2% range. However, he did not rule out the possibility that North Carolina could save even more than the Perryman Group figure of 6.2%, meaning savings could surpass $4.3 billion per year.
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Whether this same range applied to Pennsylvania required first looking at how Pennsylvania's NPrestrictions compared to those in North Carolina, Massachusetts, and Texas. Those three states have a "supervisory" regulatory structure, while Pennsylvania has a "collaborative" regulatory structure. This, however, was not a meaningful difference for studies on access and quality. Both the Reagan and Salsberry study 53 and the Kleiner et al. study 54 categorized Pennsylvania with North Carolina, Massachusetts, and Texas. This was because those studies' categories did not differ on whether the structure was "collaborative" or "supervisory," but on whether the regimes restricted diagnostic, treatment, and prescriptive authority at all. Effects were observed to be dependent on the amount of authority restricted, not on the nature of such restrictions. Because the collaborative/supervisory distinction did not matter for access and quality, and because these are inputs affecting cost, it is unlikely the collaborative/supervisory distinction would matter for cost.
Additionally, Conover's first two factors for why 0.63% is insufficient apply to Pennsylvania: the figure phases in savings over five years, and it ignores fewer hospitalizations.
Where does Pennsylvania fit? For these reasons, savings in Pennsylvania are likely in the 0.63%-6.2% range. But we made a number of adjustments to find the most conservative savings estimate. We adjusted RAND's 0.63% figure to fit better with Pennsylvania. RAND based its figure on Medical Expenditure Panel Survey (MEPS) data that indicated NP care in Massachusetts was 35 percent less costly than visits to physicians for six acute conditions (cough, throat symptoms, fever, earache, skin rash, and nasal congestion). 55 But the national average is a 20 percent savings. 56 Accessing MEPS data for Pennsylvania is prohibitively difficult for the purposes of this piece, so we used the national rate as a proxy for the Pennsylvania rate. The 0.63% total savings was thus scaled down to 0.36% to reflect the decrease from 35% to 20% in acute-condition savings.
Pennsylvania health care expenditures. After deriving a savings rate of 0.36% on total expenditures over ten years, we estimated expenditures. Pennsylvanians spent roughly $100 billion on health care in 2009, 57 which was the last year Pennsylvania-specific data was available. Pennsylvania's health care spending has historically grown at a faster rate than the national average. But conservatively applying projected national growth rates to Pennsylvania's numbers, Pennsylvanians are projected to spend $1.782 trillion on health care in the next ten years. 
